Markers sierologici dell'infiammazione nelle malattie reumatiche

Translated title of the contribution: Serologic markers of inflammation in rheumatic diseases

Pircarlo C. Sarzi-Puttini, F. Atzeni

Research output: Contribution to journalArticle

Abstract

Laboratory evaluation of inflammation in rheumatic diseases is important both to quantify the extent of inflammation and to monitor disease activity. Improvement in CRP levels is an objective indication that a drug has produced a beneficial effect and thus may be useful to the physician for monitoring effects of therapy. Since CRP and ERS may be elevated in a number of conditions besides RA, a diagnosis of RA must be made before using CRP and ERS as a prognostic factor. The introduction of sensitive assays to quantitate many inflammatory-associated cytokines increased the interest in measuring these potent inflammatory mediators; in particular, IL-6 increases rapidly after inflammatory stimuli and serum level of this cytokine correlates with the severity and course of the disease process in rheumatoid arthritis.

Translated title of the contributionSerologic markers of inflammation in rheumatic diseases
Original languageItalian
Pages (from-to)19-28
Number of pages10
JournalProgressi in Reumatologia
Volume5
Issue number1
Publication statusPublished - 2004

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Serologic markers of inflammation in rheumatic diseases'. Together they form a unique fingerprint.

  • Cite this

    Sarzi-Puttini, P. C., & Atzeni, F. (2004). Markers sierologici dell'infiammazione nelle malattie reumatiche. Progressi in Reumatologia, 5(1), 19-28.